116 related articles for article (PubMed ID: 38305509)
21. Down-regulation of peroxisome proliferator-activated receptor gamma in human cervical carcinoma.
Jung TI; Baek WK; Suh SI; Jang BC; Song DK; Bae JH; Kwon KY; Bae JH; Cha SD; Bae I; Cho CH
Gynecol Oncol; 2005 May; 97(2):365-73. PubMed ID: 15863131
[TBL] [Abstract][Full Text] [Related]
22. The interaction between RACK1 and WEE1 regulates the growth of gastric cancer cell line HGC27.
Liu C; Ren L; Wang Y; Liu Y; Xiao J
Oncol Lett; 2017 Oct; 14(4):4784-4792. PubMed ID: 29085480
[TBL] [Abstract][Full Text] [Related]
23. Fuzheng Jiedu Xiaoji formulation inhibits hepatocellular carcinoma progression in patients by targeting the AKT/CyclinD1/p21/p27 pathway.
Yang X; Feng Y; Liu Y; Ye X; Ji X; Sun L; Gao F; Zhang Q; Li Y; Zhu B; Wang X
Phytomedicine; 2021 Jul; 87():153575. PubMed ID: 33984593
[TBL] [Abstract][Full Text] [Related]
24. SALL4 promotes the tumorigenicity of cervical cancer cells through activation of the Wnt/β-catenin pathway via CTNNB1.
Chen M; Li L; Zheng PS
Cancer Sci; 2019 Sep; 110(9):2794-2805. PubMed ID: 31336010
[TBL] [Abstract][Full Text] [Related]
25. Ribosomal RACK1 promotes chemoresistance and growth in human hepatocellular carcinoma.
Ruan Y; Sun L; Hao Y; Wang L; Xu J; Zhang W; Xie J; Guo L; Zhou L; Yun X; Zhu H; Shen A; Gu J
J Clin Invest; 2012 Jul; 122(7):2554-66. PubMed ID: 22653060
[TBL] [Abstract][Full Text] [Related]
26. RACK1 promoted the growth and migration of the cancer cells in the progression of esophageal squamous cell carcinoma.
Hu F; Tao Z; Wang M; Li G; Zhang Y; Zhong H; Xiao H; Xie X; Ju M
Tumour Biol; 2013 Dec; 34(6):3893-9. PubMed ID: 23893384
[TBL] [Abstract][Full Text] [Related]
27. EXOSC5 promotes proliferation of gastric cancer through regulating AKT/STAT3 signaling pathways.
Chen X; Huang Y; Liu J; Lin W; Chen C; Chen Y; Ding Y; Yang Y; Chen Y; Wang H; Teng L
J Cancer; 2022; 13(5):1456-1467. PubMed ID: 35371329
[No Abstract] [Full Text] [Related]
28. Overexpression of RACK1 Predicts Poor Prognosis in Melanoma.
Shen C; Hua H; Gu L; Cao S; Cai H; Yao X; Chen X
J Cancer; 2020; 11(4):795-803. PubMed ID: 31949482
[TBL] [Abstract][Full Text] [Related]
29. [Effect and mechanism of circular RNA BICD2 on the biological behavior of oral squamous cell carcinoma cells].
Zhang YJ; Zhu QQ; Zhou HX; Wang HY; Zhou H
Zhonghua Kou Qiang Yi Xue Za Zhi; 2021 Nov; 56(11):1098-1108. PubMed ID: 34763405
[No Abstract] [Full Text] [Related]
30. Forced downregulation of RACK1 inhibits glioma development by suppressing Src/Akt signaling activity.
Peng R; Jiang B; Ma J; Ma Z; Wan X; Liu H; Chen Z; Cheng Q; Chen R
Oncol Rep; 2013 Nov; 30(5):2195-202. PubMed ID: 24008630
[TBL] [Abstract][Full Text] [Related]
31. RACK1 promotes lung cancer cell growth via an MCM7/RACK1/ Akt signaling complex.
Fei L; Ma Y; Zhang M; Liu X; Luo Y; Wang C; Zhang H; Zhang W; Han Y
Oncotarget; 2017 Jun; 8(25):40501-40513. PubMed ID: 28465488
[TBL] [Abstract][Full Text] [Related]
32. [Study on the correlation between combined detection of RACK1 and M2/M1 in oral squamous cell carcinoma and prognosis of the patients].
Zhu J; Xu T; Song DH; Wu SB
Shanghai Kou Qiang Yi Xue; 2022 Oct; 31(5):517-522. PubMed ID: 36758601
[TBL] [Abstract][Full Text] [Related]
33. RACK1 suppresses gastric tumorigenesis by stabilizing the β-catenin destruction complex.
Deng YZ; Yao F; Li JJ; Mao ZF; Hu PT; Long LY; Li G; Ji XD; Shi S; Guan DX; Feng YY; Cui L; Li DS; Liu Y; Du X; Guo MZ; Xu LY; Li EM; Wang HY; Xie D
Gastroenterology; 2012 Apr; 142(4):812-823.e15. PubMed ID: 22240482
[TBL] [Abstract][Full Text] [Related]
34. RACK1 forms a complex with FGFR1 and PKM2, and stimulates the growth and migration of squamous lung cancer cells.
Zhou C; Chen T; Xie Z; Qin Y; Ou Y; Zhang J; Li S; Chen R; Zhong N
Mol Carcinog; 2017 Nov; 56(11):2391-2399. PubMed ID: 28418088
[TBL] [Abstract][Full Text] [Related]
35. [Expression of RACK1 and EGP40 in oral squamous cell carcinoma and its correlation with clinicopathological features and prognosis].
Duan YH; Wu KL; Mei J; Zhou YY; Liu MS
Shanghai Kou Qiang Yi Xue; 2023 Aug; 32(4):385-390. PubMed ID: 38044732
[TBL] [Abstract][Full Text] [Related]
36. Stabilization of CCDC102B by Loss of RACK1 Through the CMA Pathway Promotes Breast Cancer Metastasis
Si J; Guo R; Xiu B; Chi W; Zhang Q; Hou J; Su Y; Chen J; Xue J; Shao ZM; Wu J; Chi Y
Front Oncol; 2022; 12():927358. PubMed ID: 35957886
[TBL] [Abstract][Full Text] [Related]
37. FGFR/RACK1 interacts with MDM2, promotes P53 degradation, and inhibits cell senescence in lung squamous cell carcinoma.
Chen T; Wang F; Wei S; Nie Y; Zheng X; Deng Y; Zhu X; Deng Y; Zhong N; Zhou C
Cancer Biol Med; 2021 Mar; 18(3):665-74. PubMed ID: 33710818
[TBL] [Abstract][Full Text] [Related]
38. OTUB1's role in promoting OSCC development by stabilizing RACK1 involves cell proliferation, migration, invasion, and tumor-associated macrophage M1 polarization.
Li Y; Li R; Qin H; He H; Li S
Cell Signal; 2023 Oct; 110():110835. PubMed ID: 37532135
[TBL] [Abstract][Full Text] [Related]
39. PRDM4 inhibits cell proliferation and tumorigenesis by inactivating the PI3K/AKT signaling pathway through targeting of PTEN in cervical carcinoma.
Yang WT; Chen M; Xu R; Zheng PS
Oncogene; 2021 May; 40(18):3318-3330. PubMed ID: 33846573
[TBL] [Abstract][Full Text] [Related]
40. RACK1 promotes prostate cancer cell proliferation, invasion and metastasis.
Shen F; Yan C; Liu M; Feng Y; Chen Y
Mol Med Rep; 2013 Oct; 8(4):999-1004. PubMed ID: 23912224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
